AR091506A1 - Derivados de indansulfamida - Google Patents

Derivados de indansulfamida

Info

Publication number
AR091506A1
AR091506A1 ARP130102174A AR091506A1 AR 091506 A1 AR091506 A1 AR 091506A1 AR P130102174 A ARP130102174 A AR P130102174A AR 091506 A1 AR091506 A1 AR 091506A1
Authority
AR
Argentina
Prior art keywords
indansulfamide
derivatives
sulfamide
inden
dihydro
Prior art date
Application number
Other languages
English (en)
Inventor
Kazuta Yuji
Watanabe Toru
Sorimachi Keiichi
Saito Minako
Kita Yoichi
Tanaka Toshiaki
Higashiyama Hiroyuki
Hanada Takahisa
Teramoto Tetsuyuki
Kosasa Takashi
Ishikawa Yukio
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of AR091506A1 publication Critical patent/AR091506A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/08—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Derivados de indansulfamida o una sal aceptable para uso farmacéutico de los mismos tales como N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihidro-1H-inden-1-il]sulfamida, N-[(1S)-2,2,4,7-tetrafluoro-2,3-dihidro-1H-inden-1-il]sulfamida, (+)-N-(2,2,4,6,7-pentafluoro-2,3-dihidro-1H-inden-1-il)sulfamida, tiene una acción que mejora el índice de Severidad de Ataques (Puntuación) en modelos inducidos con ratones. Por lo tanto, se presume que los compuestos o la sal de los mismos son fármacos para tratar la epilepsia.
ARP130102174 2012-06-21 2013-06-19 Derivados de indansulfamida AR091506A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261662626P 2012-06-21 2012-06-21
US201261709737P 2012-10-04 2012-10-04
US201361751331P 2013-01-11 2013-01-11

Publications (1)

Publication Number Publication Date
AR091506A1 true AR091506A1 (es) 2015-02-11

Family

ID=49768740

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130102174 AR091506A1 (es) 2012-06-21 2013-06-19 Derivados de indansulfamida

Country Status (34)

Country Link
US (1) US9018260B2 (es)
EP (1) EP2865663B1 (es)
JP (1) JP5883135B2 (es)
KR (1) KR101951519B1 (es)
CN (1) CN104395285B (es)
AR (1) AR091506A1 (es)
AU (1) AU2013278450B2 (es)
BR (1) BR112014031565B1 (es)
CA (1) CA2877097C (es)
CL (1) CL2014003429A1 (es)
CY (1) CY1119171T1 (es)
DK (1) DK2865663T3 (es)
ES (1) ES2628374T3 (es)
HK (1) HK1207363A1 (es)
HR (1) HRP20170863T1 (es)
HU (1) HUE033583T2 (es)
IL (1) IL236295A (es)
JO (1) JO3263B1 (es)
LT (1) LT2865663T (es)
ME (1) ME02753B (es)
MX (1) MX355261B (es)
MY (1) MY169073A (es)
NZ (1) NZ702974A (es)
PE (1) PE20150284A1 (es)
PH (1) PH12014502805B1 (es)
PL (1) PL2865663T3 (es)
PT (1) PT2865663T (es)
RS (1) RS56073B1 (es)
RU (1) RU2619937C2 (es)
SG (1) SG11201408359PA (es)
SI (1) SI2865663T1 (es)
TW (1) TWI597263B (es)
WO (1) WO2013191144A1 (es)
ZA (1) ZA201409248B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2919397C (en) 2013-09-09 2021-05-18 Peloton Therapeutics, Inc. Aryl ethers as hif-2.alpha. inhibitors for the treatment of cancer
EP3083639B1 (en) 2013-12-16 2019-05-29 Peloton Therapeutics, Inc. Cyclic sulfone and sulfoximine analogs and uses thereof
ES2673876T3 (es) * 2013-12-19 2018-06-26 Eisai R&D Management Co., Ltd. Agente terapéutico y/o preventivo que comprende un derivado de 1-indansulfamida para el dolor
EP3267792A4 (en) 2015-03-11 2018-09-26 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
WO2016145045A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Compositions for use in treating glioblastoma
WO2016144826A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
US10807948B2 (en) 2015-03-11 2020-10-20 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
WO2016168510A1 (en) 2015-04-17 2016-10-20 Peloton Therapeutics, Inc. Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
US9796697B2 (en) 2015-06-12 2017-10-24 Peloton Therapeutics, Inc. Tricyclic inhibitors of HIF-2-alpha and uses thereof
JP7265526B2 (ja) 2018-03-20 2023-04-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 てんかん治療剤
JP2024026905A (ja) * 2020-11-25 2024-02-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 てんかん治療剤
WO2023210617A1 (ja) * 2022-04-27 2023-11-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 パーキンソン病治療用医薬組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3383414A (en) 1964-08-26 1968-05-14 Sandoz Ag Benzocycloalkyl sulfamides
US3709677A (en) 1969-06-25 1973-01-09 Sandoz Ag N-substituted sulfamoyl compounds useful as herbicides
EP1401805A1 (en) * 2001-06-26 2004-03-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Valproyltaurinamide derivatives as anticonvulsant and cns active agents
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
BRPI0514278A (pt) * 2004-08-24 2008-06-10 Janssen Pharmaceutica Nv derivados de sulfamida de heteroarila benzo-fundida úteis como agentes anti-convulsivante
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
CN100572365C (zh) * 2006-01-26 2009-12-23 全哲山 用作抗癫痫药的1,2,4-三唑并[4,3-a]喹啉-1-酮衍生物及其可药用盐
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
CL2007002994A1 (es) 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
AR070949A1 (es) * 2007-10-19 2010-05-19 Solvay Pharm Gmbh Compuestos derivados de sulfamato de uso medico, medicamentos y composiciones farmaceuticas que los comprenden, procedimientos para preparar estos compuestos y su uso
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
WO2010115952A1 (en) * 2009-04-09 2010-10-14 N.V. Organon Indane derivatives
BR112012011427B8 (pt) * 2009-11-13 2021-05-25 Celgene Int Ii Sarl moduladores seletivos de receptor de esfingosina 1 fosfato, seu uso, e composição
CN102753022B (zh) * 2009-11-13 2016-04-20 瑞塞普托斯公司 选择性的杂环1-磷酸鞘氨醇受体调节剂
WO2011097337A1 (en) * 2010-02-04 2011-08-11 Advanced Neural Dynamics, Inc. Novel sulfamides exhibiting neuroprotective action and methods for use thereof
US20120077814A1 (en) * 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives

Also Published As

Publication number Publication date
JP5883135B2 (ja) 2016-03-09
US9018260B2 (en) 2015-04-28
PE20150284A1 (es) 2015-02-21
ZA201409248B (en) 2015-12-23
NZ702974A (en) 2016-03-31
AU2013278450A1 (en) 2015-01-22
AU2013278450B2 (en) 2017-04-20
RS56073B1 (sr) 2017-10-31
PL2865663T3 (pl) 2017-09-29
ME02753B (me) 2018-01-20
KR20150032838A (ko) 2015-03-30
CN104395285A (zh) 2015-03-04
SG11201408359PA (en) 2015-01-29
SI2865663T1 (sl) 2017-07-31
CA2877097A1 (en) 2013-12-27
IL236295A0 (en) 2015-02-26
HRP20170863T1 (hr) 2017-09-08
HK1207363A1 (en) 2016-01-29
PH12014502805A1 (en) 2015-02-23
MX355261B (es) 2018-04-12
RU2619937C2 (ru) 2017-05-22
BR112014031565A8 (pt) 2021-06-08
TWI597263B (zh) 2017-09-01
IL236295A (en) 2016-09-29
HUE033583T2 (hu) 2017-12-28
MX2014015492A (es) 2015-05-08
DK2865663T3 (en) 2017-06-19
KR101951519B1 (ko) 2019-02-22
EP2865663A1 (en) 2015-04-29
CY1119171T1 (el) 2018-02-14
BR112014031565A2 (pt) 2017-06-27
RU2014151013A (ru) 2016-08-10
JO3263B1 (ar) 2018-09-16
LT2865663T (lt) 2017-07-10
TW201402530A (zh) 2014-01-16
BR112014031565B1 (pt) 2022-04-12
CN104395285B (zh) 2016-04-13
EP2865663B1 (en) 2017-04-05
PT2865663T (pt) 2017-06-02
PH12014502805B1 (en) 2015-02-23
ES2628374T3 (es) 2017-08-02
WO2013191144A1 (ja) 2013-12-27
CL2014003429A1 (es) 2015-03-27
CA2877097C (en) 2018-08-07
MY169073A (en) 2019-02-13
EP2865663A4 (en) 2016-02-17
US20140371319A1 (en) 2014-12-18
JPWO2013191144A1 (ja) 2016-05-26

Similar Documents

Publication Publication Date Title
AR091506A1 (es) Derivados de indansulfamida
CR20150326A (es) Inhibidores de autotaxina
CL2016001889A1 (es) (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1.
CL2018000542A1 (es) Nuevos derivados de fenoximetilo.
DOP2017000048A (es) Compuestos aminopirimidinilo como inhibidores de jak.
CL2016002573A1 (es) Compuesto de ciclopropanamina y sus usos.
CL2018000687A1 (es) Nuevos compuestos bicíclicos como inhibidores de atx.
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
CL2016001911A1 (es) Compuesto heterocíclico fusionado
BR112017007305A2 (pt) estruturas fibrosas com aberturas e métodos para a produção das mesmas
ES2769863T8 (es) 7-hidroxi-cannabidivarín (7-OH-CBDV) para usar en el tratamiento de la epilepsia
CR20160564A (es) Dinucleótidos cíclicos como moduladores de sting
UY35821A (es) Compuesto heterocíclico
CL2013002612A1 (es) Compuestos derivados de c4-monometil triterpenoides; composicion farmaceutica que los comprende; y metodo para tratar o prevenir una enfermedad o un trastorno.
BR112016015838A2 (pt) compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação
BR112017007123A2 (pt) derivados de tetrahidroisoquinolina
BR112015011112A2 (pt) composto oligomérico, oligômero, composição farmacêutica, uso do composto oligomérico, método de síntese de um composto oligomérico e método de tratamento de uma doença.
DK3292116T3 (da) 3-aryl-4-amido-bicykliske [4,5,0]hydroxamsyrer som hdac-inhibitorer
BR112014017673A8 (pt) Compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
CL2015001279A1 (es) Compuestos derivados de piridina, inhibidores del transportador de uratos urat 1; composicion farmaceutica que los comprende; uso para el tratamiento o prevencion de enfermedades tales como gota, hiperuricemia, hipertensión, enfermedades renales, entre otras.
BR112018005754A2 (pt) benzamidas substituídas por isoxazolina e análogos como inseticidas.
CL2014003472A1 (es) Pro-farmacos derivados de (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-oxo-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)acrilamida; composicion farmaceutica que los comprende; y su uso para tratar una infeccion bacteriana.
CL2014000490A1 (es) Compuestos derivados de pirazol y sus sales, con actividad inhibidora de sglt1; composicion farmaceutica que los comprende; y su uso para tratar o prevenir diabetes.
DOP2014000098A (es) 2-tiopirimidinonas
DK3113761T3 (da) Mikrokapsler indeholdende aktivt middel

Legal Events

Date Code Title Description
FG Grant, registration